1331 related articles for article (PubMed ID: 24076216)
41. IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.
Duan S; Huang W; Liu X; Liu X; Chen N; Xu Q; Hu Y; Song W; Zhou J
J Exp Clin Cancer Res; 2018 Dec; 37(1):304. PubMed ID: 30518405
[TBL] [Abstract][Full Text] [Related]
42. Hepatic stellate cells promote upregulation of epithelial cell adhesion molecule and epithelial-mesenchymal transition in hepatic cancer cells.
Nagahara T; Shiraha H; Sawahara H; Uchida D; Takeuchi Y; Iwamuro M; Kataoka J; Horiguchi S; Kuwaki T; Onishi H; Nakamura S; Takaki A; Nouso K; Yamamoto K
Oncol Rep; 2015 Sep; 34(3):1169-77. PubMed ID: 26165819
[TBL] [Abstract][Full Text] [Related]
43. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation.
Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI
Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644
[TBL] [Abstract][Full Text] [Related]
44. ARHGAP9 inhibits colorectal cancer cell proliferation, invasion and EMT via targeting PI3K/AKT/mTOR signaling pathway.
Sun J; Zhao X; Jiang H; Yang T; Li D; Yang X; Jia A; Ma Y; Qian Z
Tissue Cell; 2022 Aug; 77():101817. PubMed ID: 35679685
[TBL] [Abstract][Full Text] [Related]
45. Snail promotes cell migration through PI3K/AKT-dependent Rac1 activation as well as PI3K/AKT-independent pathways during prostate cancer progression.
Henderson V; Smith B; Burton LJ; Randle D; Morris M; Odero-Marah VA
Cell Adh Migr; 2015; 9(4):255-64. PubMed ID: 26207671
[TBL] [Abstract][Full Text] [Related]
46. LINC00152 promotes proliferation in hepatocellular carcinoma by targeting EpCAM via the mTOR signaling pathway.
Ji J; Tang J; Deng L; Xie Y; Jiang R; Li G; Sun B
Oncotarget; 2015 Dec; 6(40):42813-24. PubMed ID: 26540343
[TBL] [Abstract][Full Text] [Related]
47. Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.
Driemel C; Kremling H; Schumacher S; Will D; Wolters J; Lindenlauf N; Mack B; Baldus SA; Hoya V; Pietsch JM; Panagiotidou P; Raba K; Vay C; Vallböhmer D; Harréus U; Knoefel WT; Stoecklein NH; Gires O
Oncogene; 2014 Oct; 33(41):4904-15. PubMed ID: 24141784
[TBL] [Abstract][Full Text] [Related]
48. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
[TBL] [Abstract][Full Text] [Related]
49. Knockdown of DEPTOR inhibits cell proliferation and increases chemosensitivity to melphalan in human multiple myeloma RPMI-8226 cells via inhibiting PI3K/AKT activity.
Zhang HR; Chen JM; Zeng ZY; Que WZ
J Int Med Res; 2013 Jun; 41(3):584-95. PubMed ID: 23613505
[TBL] [Abstract][Full Text] [Related]
50. Down-regulation of E-cadherin enhances prostate cancer chemoresistance via Notch signaling.
Wang W; Wang L; Mizokami A; Shi J; Zou C; Dai J; Keller ET; Lu Y; Zhang J
Chin J Cancer; 2017 Mar; 36(1):35. PubMed ID: 28356132
[TBL] [Abstract][Full Text] [Related]
51. Disruption of the PI3K/AKT/mTOR signaling cascade and induction of apoptosis in HL-60 cells by an essential oil from Monarda citriodora.
Pathania AS; Guru SK; Verma MK; Sharma C; Abdullah ST; Malik F; Chandra S; Katoch M; Bhushan S
Food Chem Toxicol; 2013 Dec; 62():246-54. PubMed ID: 23994707
[TBL] [Abstract][Full Text] [Related]
52. KRAS gene silencing inhibits the activation of PI3K-Akt-mTOR signaling pathway to regulate breast cancer cell epithelial-mesenchymal transition, proliferation and apoptosis.
Zhang Y; Liu JL; Wang J
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3085-3096. PubMed ID: 32271426
[TBL] [Abstract][Full Text] [Related]
53. Transmembrane-4 L-six family member-1 (TM4SF1) promotes non-small cell lung cancer proliferation, invasion and chemo-resistance through regulating the DDR1/Akt/ERK-mTOR axis.
Ye L; Pu C; Tang J; Wang Y; Wang C; Qiu Z; Xiang T; Zhang Y; Peng W
Respir Res; 2019 May; 20(1):106. PubMed ID: 31142317
[TBL] [Abstract][Full Text] [Related]
54. Bone marrow mesenchymal stem cells promote head and neck cancer progression through Periostin-mediated phosphoinositide 3-kinase/Akt/mammalian target of rapamycin.
Liu C; Feng X; Wang B; Wang X; Wang C; Yu M; Cao G; Wang H
Cancer Sci; 2018 Mar; 109(3):688-698. PubMed ID: 29284199
[TBL] [Abstract][Full Text] [Related]
55. Anticancer Effects of Morusin in Prostate Cancer via Inhibition of Akt/mTOR Signaling Pathway.
Wu HE; Su CC; Wang SC; Liu PL; Cheng WC; Yeh HC; Chuu CP; Chen JK; Bao BY; Lee CH; Ke CC; Chen YR; Yu YH; Huang SP; Li CY
Am J Chin Med; 2023; 51(4):1019-1039. PubMed ID: 37120705
[TBL] [Abstract][Full Text] [Related]
56. Differential gene expression profiling of functionally and developmentally distinct human prostate epithelial populations.
Liu H; Cadaneanu RM; Lai K; Zhang B; Huo L; An DS; Li X; Lewis MS; Garraway IP
Prostate; 2015 May; 75(7):764-76. PubMed ID: 25663004
[TBL] [Abstract][Full Text] [Related]
57. EpCAM expression in the prostate cancer makes the difference in the response to growth factors.
Yoshida GJ; Saya H
Biochem Biophys Res Commun; 2014 Jan; 443(1):239-45. PubMed ID: 24309103
[TBL] [Abstract][Full Text] [Related]
58. EpCAM expression in breast cancer cells is associated with enhanced bone metastasis formation.
Hiraga T; Ito S; Nakamura H
Int J Cancer; 2016 Apr; 138(7):1698-708. PubMed ID: 26576938
[TBL] [Abstract][Full Text] [Related]
59. EHMT2 promotes the development of prostate cancer by inhibiting PI3K/AKT/mTOR pathway.
Fan HT; Shi YY; Lin Y; Yang XP
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7808-7815. PubMed ID: 31599405
[TBL] [Abstract][Full Text] [Related]
60. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer.
Ren S; Liu Y; Xu W; Sun Y; Lu J; Wang F; Wei M; Shen J; Hou J; Gao X; Xu C; Huang J; Zhao Y; Sun Y
J Urol; 2013 Dec; 190(6):2278-87. PubMed ID: 23845456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
